We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+40.41%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.93B
AUM Growth
+$710M
Cap. Flow
+$347M
Cap. Flow %
17.99%
Top 10 Hldgs %
33.69%
Holding
94
New
31
Increased
15
Reduced
22
Closed
18

Top Buys

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$61.8M
2
LH icon
Labcorp
LH
+$50M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$48.9M
4
AZN icon
AstraZeneca
AZN
+$32.8M
5
HOLX
Hologic
HOLX
+$30.1M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$38.5M
2
BDX icon
Becton Dickinson
BDX
+$34.7M
3
CI icon
Cigna
CI
+$34.5M
4
ELV icon
Elevance Health
ELV
+$33.1M
5
COR icon
Cencora
COR
+$30M

Sector Composition

Rank Sector Weight
1 Healthcare 66.7%
2 Technology 4.27%
3 Consumer Discretionary 1.32%
4 Industrials 0.62%
5 Financials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMU
51
CALL
DELISTED
Immunomedics Inc
IMMU
$12.8M 0.66%
360,000
-87,700
-20% -$2.56M
NVRO
52
DELISTED
NEVRO CORP.
NVRO
$12.4M 0.65%
+104,180
New +$12.4M
IWM icon
53
CALL
iShares Russell 2000 ETF
IWM
$81.5B
$12.2M 0.63%
+85,200
New +$11.2M
DE icon
54
Deere & Co
DE
$163B
$12M 0.62%
76,336
+36,128
+90% +$5.23M
JNJ icon
55
Johnson & Johnson
JNJ
$613B
$10.9M 0.56%
77,167
-89,208
-54% -$13M
APTV icon
56
Aptiv
APTV
$12.1B
$10.7M 0.56%
+137,757
New +$9.48M
THC icon
57
Tenet Healthcare
THC
$20.1B
$10.5M 0.54%
+578,625
New +$11.4M
DVAX
58
DELISTED
Dynavax Technologies
DVAX
$10.1M 0.53%
+1,143,526
New +$5.78M
DGX icon
59
Quest Diagnostics
DGX
$25.6B
$10.1M 0.53%
+88,933
New +$9.43M
XLF icon
60
CALL
State Street Financial Select Sector SPDR ETF
XLF
$58B
$10M 0.52%
+433,600
New +$9.85M
XLI icon
61
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$9.35M 0.49%
+136,100
New +$8.83M
SHOP icon
62
Shopify
SHOP
$152B
$8.97M 0.47%
94,540
– –
IGMS
63
DELISTED
IGM Biosciences
IGMS
$8.47M 0.44%
115,988
-47,117
-29% -$2.86M
V icon
64
Visa
V
$683B
$8.4M 0.44%
+43,468
New +$7.94M
LAB icon
65
Standard BioTools
LAB
$339M
$7.72M 0.4%
1,924,072
-749,018
-28% -$2.61M
CHRS icon
66
Coherus Oncology
CHRS
$222M
$7.35M 0.38%
411,727
-62,328
-13% -$1.05M
TRIL
67
DELISTED
Trillium Therapeutics Inc.
TRIL
$6.92M 0.36%
+855,270
New +$5.29M
ZEN
68
DELISTED
ZENDESK INC
ZEN
$5.93M 0.31%
+67,034
New +$5.16M
NEE icon
69
NextEra Energy
NEE
$181B
$4.94M 0.26%
82,280
+29,000
+54% +$1.74M
PCRX icon
70
PUT
Pacira BioSciences
PCRX
$1.06B
$3.15M 0.16%
+60,000
New +$2.51M
IMVT icon
71
Immunovant
IMVT
$7.91B
$1.64M 0.08%
+67,163
New +$1.44M
ALNA
72
DELISTED
Allena Pharmaceuticals
ALNA
$449K 0.02%
284,285
– –
ALNY icon
73
Alnylam Pharmaceuticals
ALNY
$29.5B
– –
-81,804
Closed -$8.9M
BABA icon
74
Alibaba
BABA
$305B
– –
-70,083
Closed -$13.6M
BDX icon
75
Becton Dickinson
BDX
$46.9B
– –
-154,929
Closed -$34.7M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q2 2020 Portfolio in Review

As of Q2 2020, PFM Health Sciences held 94 positions worth $1.93B, up 58% from $1.22B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences deployed $347M of net new capital in Q2 2020, opening 31 new positions and adding to 15 existing holdings. Its largest new stake was Labcorp: 361,224 shares worth $51.5M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 84% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Elevance Health, an estimated $33.1M trimmed.

  • PFM Health Sciences's largest Q2 2020 buy was Labcorp: 361,224 shares worth $51.5M.
  • PFM Health Sciences added most to Immunomedics Inc in Q2 2020, an estimated $61.8M increase.
  • PFM Health Sciences's biggest Q2 2020 reduction was Elevance Health, cutting an estimated $33.1M.
  • PFM Health Sciences fully exited Pfizer in Q2 2020, selling an estimated $38.5M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $1.93B portfolio in Q2 2020.
  • PFM Health Sciences opened 31 new positions and closed 18 in Q2 2020.
  • PFM Health Sciences's portfolio value rose 58% quarter-over-quarter to $1.93B.

Based on PFM Health Sciences's 13F filing for Q2 2020, filed 14 Aug 2020.